LYBALVI
LIVE

Serial Number

90765835

Owner

Alkermes Pharma Ireland Limited

Attorney

Norm J. Rich

First Use Date

Jan 21, 2022

Filing Date

Jun 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LYBALVI Trademark

Serial Number: 90765835 • Registration: 8111270

LYBALVI is a trademark filed by Alkermes Pharma Ireland Limited on June 10, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Alkermes Pharma Ireland Limited (87 trademarks)

Connaught House
Dublin 4 , IE

Entity Type: 99

Trademark Details

Filing Date

June 10, 2021

Registration Date

January 20, 2026

First Use Anywhere

January 21, 2022

First Use in Commerce

February 23, 2022

Published for Opposition

May 31, 2022

Goods & Services

Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms

Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program

Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes

Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 30, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 30, 2025 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 26, 2023 SUPC
SOU EXTENSION 1 GRANTED
May 26, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 25, 2023 AITU
SOU EXTENSION 1 FILED
May 19, 2023 EXT1
USE AMENDMENT FILED
May 19, 2023 IUAF
SOU TEAS EXTENSION RECEIVED
May 19, 2023 EEXT
TEAS STATEMENT OF USE RECEIVED
May 19, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
NEW NOA TO ISSUE
Oct 17, 2022 NEWN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2022 NOAM
NOTICE OF ALLOWANCE CANCELLED
Jul 26, 2022 IUCN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 26, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 26, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 26, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 26, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 15, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 29, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 14, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 14, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 14, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 14, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 11, 2022 ZZZX
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Mar 11, 2022 PBMR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 1, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2021 NWOS
NEW APPLICATION ENTERED
Jun 14, 2021 NWAP